Navigation Links
PAREXEL Expands Global Clinical Pharmacology Capabilities
Date:3/31/2008

BOSTON, March 31 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, today announced that the Company had completed the expansion of three Clinical Pharmacology Research Units located in Baltimore, Maryland in the United States; London, United Kingdom; and Berlin, Germany in order to meet growing client demand for expertise-based studies in the early phases of clinical development.

"Continued expansion of local capabilities combined with an integrated global clinical pharmacology presence has been a cornerstone of PAREXEL's leadership in early clinical development. As biopharmaceutical companies have been conducting more Phase I and Proof of Concept studies with increasing complexity, PAREXEL has been well positioned to meet their needs. In this regard, we are a top provider of expertise-based Phase I services and have more than 550 beds, which is among the largest capacities worldwide," said Herman Scholtz, M.D., Head of International Clinical Pharmacology, PAREXEL. "Clients rely on our in-depth medical and therapeutic expertise to help them conduct rigorous clinical trials in order to identify and select promising new compounds." Dr. Scholtz added, "Long before hospital-based units became an industry best practice, PAREXEL saw the benefit of that approach and located our clinical pharmacology research units in hospitals in order to provide a safe, high-quality environment for early phase development activities."

In Baltimore, PAREXEL's Clinical Pharmacology Research Unit has been expanding capabilities and capacity for client programs since 2001, when the unit opened. With its most recent expansion, the unit now has 90 beds, representing the larg
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
2. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
3. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
4. Cellectar Expands Clinical Management Team
5. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
6. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
7. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
8. Gates Foundation Seeks Proposals for Innovative Global Health Research
9. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 Thousands of people will peacefully ... the opioid addiction epidemic at dozens of rallies across ... 2008, the United States has ... prescription opioids and heroin, yet the President has never ... worded letter to President Obama , rally organizers ...
(Date:8/31/2015)... ALBANY, New York , August 31, 2015 ... Research report states that the global cardiovascular monitoring ... in 2012 and is predicted to reach a ... at a CAGR of 9.7% between 2013 and ... Monitoring and Diagnostic Devices Market (ECG, Holter Monitors, ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015  The departments ... an event today at Gaudenzia Concept 90 to raise ... drug overdose crisis in Pennsylvania ... treatment and focus on recovery through the Building ... many Pennsylvanians are dying every day to a disease ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... MOUNTAIN VIEW, Calif., Aug. 12 As more and more ... spinal surgery techniques, the negatives of the spinal fusion market ... five years, the industry expects to see a steady inflow ... in the market. (Logo:   http://www.medicaldevices.frost.com ), ...
... Nev., Aug. 13 PDL BioPharma, Inc. (PDL) (Nasdaq: ... and the PDL BioPharma logo are considered trademarks of ... This press release contains forward-looking statements. Each ... results may differ materially from those, express or implied, ...
Cached Medicine Technology:Frost & Sullivan: Innovative Products and Technologies Strengthen U.S. Spinal Surgery Market 2PDL BioPharma Receives Letter from Genentech Relating to European Patents 2
(Date:9/1/2015)... ... September 01, 2015 , ... e-Spirit ... version 5.2 of the FirstSpirit Content Management System with new capabilities and enhancements ... version of FirstSpirit, companies will be well on their way to achieving digital ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the Massachusetts-based charity ... (FSHD), will be the beneficiary of a collection of fundraising events this fall. From ... of the FSH Society and further FSHD research. , The list of ...
(Date:9/1/2015)... ... September 01, 2015 , ... METTLER ... Instruments in accordance with GMP requirements“ , featuring Ed Szczesny (Quality Assurance, Rhodes ... at 11:00 EDT (15:00 GMT). , Calibration, qualification, and the appropriate level ...
(Date:9/1/2015)... ... 01, 2015 , ... CanAm Enterprises LLC, (“CanAm”) is pleased ... cards (I-829 petition approval) from the USCIS through an investment in one of ... the EB-5 visa process for immigrant investors to become lawful permanent residents of ...
(Date:9/1/2015)... Florida (PRWEB) , ... September 01, 2015 , ... ... language barriers and international borders seldom arise at the most convenient time for ... is always ready to help. , Universal Translation Services has real ...
Breaking Medicine News(10 mins):Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3
... cardiologists have searched for ways to see dangerous blood ... at Washington University School of Medicine in St. Louis ... and make them visible to a new kind of ... a Washington University cardiologist at Barnes-Jewish Hospital, these nanoparticles ...
... unexpected benefit of osteoporosis treatment that people taking ... without osteoporosis, they appear to be gaining an extra ... the Journal of Clinical Endocrinology and Metabolism , ... John Eisman, from Sydney,s Garvan Institute of Medical Research, ...
... German . Lung tumors are the number one ... is lung cancer. Each year, there are 50,000 new cases of ... detected, the greater the chance of healing the patient. But early ... chronic inflammatory reactions. To get a more complete diagnosis, the patient ...
... delivered intranasally, vaccine was found to be more effective, Funding ... PROVIDENCE, R.I. A new study led ... University of Rhode Island (URI) and EpiVax. Inc, a privately ... potential vaccine capable of reducing colonization of Helicobacter pylori ...
... ( www.elsevier.com ), the leading global publisher of ... announced today that it acquired the oncology portfolio ... LP., (operated as Cancer Information Group). The journals ... articles that disseminate cutting-edge data to physicians, medical ...
... HealthDay Reporter , TUESDAY, Feb. 1 (HealthDay News) -- ... blood pressure and cholesterol levels -- both primary risk ... According to the latest report from the U.S. Centers ... have hypertension (high blood pressure), about the same proportion ...
Cached Medicine News:Health News:New nanoparticles make blood clots visible 2Health News:New nanoparticles make blood clots visible 3Health News:An extra 5 years of life an unexpected benefit of osteoporosis treatment 2Health News:Early detection of lung cancer 2Health News:New study identifies potential vaccine to prevent gastritis, ulcer disease, gastric cancer 2Health News:Half of Adults Have Hypertension or High Cholesterol: CDC 2Health News:Half of Adults Have Hypertension or High Cholesterol: CDC 3
... Mammography has been FDA approved, and represents ... It is the first and only mammography ... - the highest available. SenoScan's larger field ... breast support is more comfortable and helps ...
... P3000 heralds a new concept in pupillometry, designed ... optical system developed for the P2000. We ... which we have paid particular attention to the ... new system is extremely flexible, allowing you to ...
... most useful features is the PupilFit software ... analysis of the pupil images, producing accurate, ... The fitted circle is shown as a ... that the measurement ismeaningful, and not just ...
... urine analyzer that ensures accurate results, test ... by reducing "hands on" operator time. And ... ideal fit for work areas large or ... is designed for continuous sample processing of ...
Medicine Products: